$VYGR Voyager Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Voyager Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Voyager Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Voyager Therapeutics, Inc. for free.

CIK Number: 0001640266
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: VYGR
Company Address: 75 SIDNEY STREET CAMBRIDGE 02139
Phone number: 857-259-5340

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Market Capitalization: $316.10M
Prev close: $11.76
Average Daily Volume: 96,244
Days Low: $11.60
Year Low: $8.12
Year High: $18.25

Voyager Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Dorval AllisonChief Financial Officer109,8941,292,353shares bought: 116,500 / shares sold: -9,256 STRONG BUYMar 23 202122 days ago
Hesslein Robert W.Senior VP & General Counsel110,0561,294,259shares bought: 122,917 / shares sold: -6,277 STRONG BUYApr 07 20217 days ago
Khwaja OmarSee Remarks124,0251,458,534shares bought: 131,000 / shares sold: -3,500 STRONG BUYMar 23 202122 days ago
Turenne AndrePresident & CEO322,3753,791,130shares bought: 257,500 / shares sold: -21,148 STRONG BUYMar 23 202122 days ago

View all Voyager Therapeutics, Inc. insiders.

Voyager Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 07 2021VYGRVoyager Therapeuti ...Hesslein Robert W.Senior VP & General ...BuyS4.953,29216,295110,056106.8 K to 110.1 K (+3.08 %)
Mar 23 2021VYGRVoyager Therapeuti ...Khwaja OmarSee RemarksGrantA0.0035,0000124,02589 K to 124 K (+39.31 %)
Mar 23 2021VYGRVoyager Therapeuti ...Hesslein Robert W.Senior VP & General ...GrantA0.0030,0000113,34883.3 K to 113.3 K (+35.99 %)
Mar 23 2021VYGRVoyager Therapeuti ...Turenne AndrePresident & CEOGrantA0.0080,0000322,375242.4 K to 322.4 K (+33.01 %)
Mar 23 2021VYGRVoyager Therapeuti ...Dorval AllisonChief Financial Off ...GrantA0.0030,0000109,89479.9 K to 109.9 K (+37.55 %)
Feb 18 2021VYGRVoyager Therapeuti ...Khwaja OmarSee RemarksOption ExerciseA7.3372,000527,76072,000
Feb 18 2021VYGRVoyager Therapeuti ...Khwaja OmarSee RemarksGrantA0.0036,000089,02553 K to 89 K (+67.89 %)
Feb 18 2021VYGRVoyager Therapeuti ...Hesslein Robert W.Senior VP & General ...Option ExerciseA7.3368,000498,44068,000
Feb 18 2021VYGRVoyager Therapeuti ...Hesslein Robert W.Senior VP & General ...GrantA0.0034,000083,34849.3 K to 83.3 K (+68.90 %)
Feb 18 2021VYGRVoyager Therapeuti ...Dorval AllisonChief Financial Off ...Option ExerciseA7.3368,000498,44068,000
Feb 18 2021VYGRVoyager Therapeuti ...Dorval AllisonChief Financial Off ...GrantA0.0034,000079,89445.9 K to 79.9 K (+74.08 %)
Feb 16 2021VYGRVoyager Therapeuti ...Dorval AllisonChief Financial Off ...SellS7.553,18624,05445,89449.1 K to 45.9 K (-6.49 %)
Feb 16 2021VYGRVoyager Therapeuti ...Hesslein Robert W.Senior VP & General ...SellS7.553,18624,05449,34852.5 K to 49.3 K (-6.06 %)
Jan 14 2021VYGRVoyager Therapeuti ...Turenne AndrePresident & CEOSellS8.6210,44390,019156,352166.8 K to 156.4 K (-6.26 %)
Jan 14 2021VYGRVoyager Therapeuti ...Dorval AllisonChief Financial Off ...SellS8.622,94225,36049,08052 K to 49.1 K (-5.66 %)

View all Voyager Therapeutics, Inc. insider transactions.